| 今开：4.16 | 昨收：4.16 |
| 最高：4.252 | 最低：4.09 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.44787695E8 |
Aldeyra Therapeutics(ALDX)02-15 05:55
$Aldeyra Therapeutics(ALDX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-036469 Act: 34 Size: 59 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)03-13 04:05
$Aldeyra Therapeutics(ALDX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002180 Act: 33 Size: 9 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)03-13 08:05
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-030309 Size: 9 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)03-08 05:15
$Aldeyra Therapeutics(ALDX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-027933 Act: 34 Size: 11 MB 网页链接查看全文
Aldeyra Therapeutics(ALDX)03-08 05:45
$Aldeyra Therapeutics(ALDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-062265 Act: 33 Size: 30 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)03-08 05:55
$Aldeyra Therapeutics(ALDX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-062277 Act: 33 Size: 66 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)03-28 19:05
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-24-026871 Act: 34 Size: 233 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)04-09 05:35
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-008171 Size: 11 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)04-18 04:15
$Aldeyra Therapeutics(ALDX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-045108 Size: 6 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)04-25 19:05
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-24-035953 Act: 34 Size: 20 MB 网页链接查看全文
智通财经APP获悉，2月7日，Aldeyra Therapeutics(ALDX.US)宣布FDA已接受其在研眼药水Reproxalap治疗干眼症的新药申请。FDA预计在2023年11月23日前完成审查。据悉，Reproxalap是一种潜在首创小分子促炎性活性醛类物质(RASP)抑制剂，能降... 网页链接
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-052056 Act: 34 Size: 6 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-24-035953 Act: 34 Size: 20 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001104 Act: 33 Size: 1 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-104887 Act: 34 Size: 1 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-104862 Act: 34 Size: 1 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-104866 Act: 34 Size: 787 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-045108 Size: 6 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-045113 Size: 6 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-008171 Size: 11 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-007959 Size: 13 KB 网页链接